Patents by Inventor Ingo Ulrich LANG

Ingo Ulrich LANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES
    Publication number: 20240398845
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in a non-human mammal/non-human mammal patient excluding a feline, in particular a canine/canine patient.
    Type: Application
    Filed: July 26, 2022
    Publication date: December 5, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, José MATALLO
  • COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN
    Publication number: 20240390317
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof in combination with pimobendan and/or telmisartan or pharmaceutically acceptable forms thereof, in particular for the prophylaxis and/or treatment of one or more cardiac diseases in a non-human mammal/non-human mammal patient, such as a dog or a cat.
    Type: Application
    Filed: May 17, 2024
    Publication date: November 28, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, José MATALLO, Tanja Margrit ZIMMERING
  • Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
    Publication number: 20240390332
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof in combination with telmisartan or pharmaceutically acceptable forms thereof, in particular for the prophylaxis and/or treatment of one or more renal diseases and/or hypertension in a non-human mammal/non-human mammal patient, such as a dog or a cat.
    Type: Application
    Filed: May 17, 2024
    Publication date: November 28, 2024
    Inventors: Carla KROH, Silke HAAG-DIERGARTEN, Ingo Ulrich LANG, Dagmar Maria POLOTZEK, Tanja Margrit ZIMMERING
  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS
    Publication number: 20240307426
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more renal diseases in a non-human mammal, such as a carnivore, in particular a cat or a dog.
    Type: Application
    Filed: July 26, 2022
    Publication date: September 19, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, José MATALLO
  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
    Publication number: 20240050456
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in feline animals.
    Type: Application
    Filed: October 6, 2023
    Publication date: February 15, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, Horst ROSE, Franziska ROESSNER, Saskia KLEY
  • Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
    Patent number: 11826378
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in feline animals.
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: November 28, 2023
    Inventors: Carla Kroh, Ingo Ulrich Lang, Horst Rose, Franziska Roessner, Saskia Kley
  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
    Publication number: 20210260090
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in feline animals
    Type: Application
    Filed: February 16, 2021
    Publication date: August 26, 2021
    Inventors: Carla KROH, Ingo Ulrich LANG, Horst ROSE, Franziska ROESSNER, Saskia KLEY